185 related articles for article (PubMed ID: 30716000)
1. A Comparative Study of Opioid Switching to Methadone for Cancer Pain Control in Successful and Unsuccessful Cases.
Okayama S; Matsuda Y; Yoshikawa Y
J Palliat Med; 2019 Jul; 22(7):844-847. PubMed ID: 30716000
[No Abstract] [Full Text] [Related]
2. Opioid Rotation to Methadone for Refractory Cancer Pain: A Case Series.
Khoo SY; Aziz FA; Nambbiar P
J Pain Palliat Care Pharmacother; 2019; 33(3-4):125-130. PubMed ID: 31638444
[TBL] [Abstract][Full Text] [Related]
3. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
[TBL] [Abstract][Full Text] [Related]
4. Clinical Outcomes of Start-Low, Go-Slow Methadone Initiation for Cancer-Related Pain: What's the Hurry?
Hawley P; Chow L; Fyles G; Shokoohi A; O'Leary MJ; Mittelstadt M
J Palliat Med; 2017 Nov; 20(11):1244-1251. PubMed ID: 28595027
[TBL] [Abstract][Full Text] [Related]
5. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting.
Okayama S; Matsuda Y
J Hosp Palliat Nurs; 2021 Dec; 23(6):539-543. PubMed ID: 34334770
[TBL] [Abstract][Full Text] [Related]
6. Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study.
Rhondali W; Tremellat F; Ledoux M; Ciais JF; Bruera E; Filbet M
J Palliat Med; 2013 Nov; 16(11):1382-7. PubMed ID: 24116946
[TBL] [Abstract][Full Text] [Related]
7. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
8. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
9. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
[TBL] [Abstract][Full Text] [Related]
10. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
[TBL] [Abstract][Full Text] [Related]
11. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-Related Pain: The EQUIMETH2 Trial (Methadone for Cancer-Related Pain).
Poulain P; Berleur MP; Lefki S; Lefebvre D; Chvetzoff G; Serra E; Tremellat F; Derniaux A; Filbet M;
J Pain Symptom Manage; 2016 Nov; 52(5):626-636.e1. PubMed ID: 27693901
[TBL] [Abstract][Full Text] [Related]
14. Methadone switching for refractory cancer pain.
Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
BMC Palliat Care; 2022 Nov; 21(1):191. PubMed ID: 36324113
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
16. Intravenous methadone in a patient with advanced cancer.
Picco Brunetto AG
BMJ Support Palliat Care; 2019 Sep; 9(3):277-279. PubMed ID: 30274971
[TBL] [Abstract][Full Text] [Related]
17. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
18. Morphine infusor pump switch to oral methadone.
Santos Suárez J; Del Valle Arnáez G
BMJ Support Palliat Care; 2020 Mar; 10(1):1-3. PubMed ID: 30944123
[TBL] [Abstract][Full Text] [Related]
19. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.
Mercadante S
Pain Med; 2012 Mar; 13(3):399-404. PubMed ID: 22360828
[TBL] [Abstract][Full Text] [Related]
20. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.
Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P
Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
